Navigation Links
ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community
Date:8/6/2008

tly include the following:

Channel: hERG hERG KvLQT1-MinK Kir2.1 Kv1.5

Cell Type: HEK293 CHO CHO HEK293 HEK293

Channel: Kv4.3 HCN4 Nav1.7 Kv1.3

Cell Type: HEK293 HEK293 CHO HEK293

ChanTest scientists were the first to prove hERG as the target for adverse cardiac events linked to non-cardiac drugs: Seldane (terfenadine), Propulsid (cisapride), and Nizoral (ketoconazole), and ChanTest pioneered the development of functional, cell-based ion channel testing as a means to predict cardiac side effects produced by non-cardiac drugs. Such testing is now a standard component of regulatory submissions prior to the approval of drugs for use in humans. ChanTest is committed to innovation, and is leading the next major advance in ion channel research and services with a $10 million program to develop the world's most extensive library or catalog of ion channels. ChanTest's expert electrophysiologists fully validate the ion channels for interrogation with functional, pharmacological, and biochemical assays.

About ChanTest

The preeminent ion channel services company, ChanTest serves its drug discovery and development customers with GLP safety and automated screening assays using its library of ion channel-expressing cell lines -- the most comprehensive in the world. Since its inception in 1998, ChanTest has tested some 20,000 compounds for approximately 400 global pharmaceutical and biotech companies -- helping them to achieve their drug safety and discovery goals. ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately -- to help make better, safer drugs. The company also offers a selection of its validated cell lines directly to customers for use in their internal research. Because of ChanTest's seminal role in this field, along with the company's uncompromising commitment to qualit
'/>"/>

SOURCE ChanTest
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Drug Discovery Technology, Booth 839
2. ChanTest Launches Redesigned Web Site
3. ChanTest to Highlight Most-Comprehensive Range of Ion Channel Profiling Screens and Consultation Services at 14th Annual SBS Conference, Booth 1104
4. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
5. Ingenuity Systems Launches Analysis Services
6. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
7. iNutrition Launches New Fission Fruit Nutrition Bars
8. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
9. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
10. Ranbaxy Launches Omeprazole 40 mg Capsules
11. Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Dec. 4 MedImmune today announced ... patients with chronic asthma to,determine the sa...nal antibody,(MAb) that targets the interleukin-5...inhibiting the IL-5R pathway may lead to a targete...porting continued study of this antibody. , ...
(Date:12/4/2008)... Azur Pharma Limited ("Azur") toda... agreement with BioSante,Pharmaceuticals, Inc ("B...to,Elestrin(TM). Elestrin is a fast drying gel fo... treatment of moderate to severe vasomotor symptom...d by the U.S. Food and Drug,Administration ("FDA"...
(Date:12/4/2008)...oduces New Trade Name Onrigin(TM) for Laromustine ...rstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulle... related to events in connection with the 50th Ame...Moscone Center in San Francisco from December 6-9,..., , The Company announced that it would pres...
(Date:12/4/2008)... 4 Parion Sciences, Inc. today ann... GILD ), has initiated a Phase I,clinical trial...afety and,tolerability of the investigational com...ration for the treatment of pulmonary disease. Pr...sodium channel (ENaC) blocker discovered by,Pario...
Breaking Biology Technology:MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3
...ailFoundry , a line of anti-spam equipment and ser...w includes a plan for small businesses. MailFoundr...ccounts. , ,To use the service, a company would ro...ould be filtered and then sent back to the company... hosted services, MailFoundry also offers a rack-m...
...g an Oracle-based e-mail installation and trying t...fees, based on a pilot program that lasted for at ... insurmountable technical difficulties cropped up....inistration Secretary Steve Bablitch said in a let...lidated e-mail system, which would have served 44,...
...ypus Technologies has appointed Rich Schifreen, vi...poration, to its board of directors. , ,The firms ...typus develops slides and other surfaces using na...a new liquid crystal technology. Mirus focuses o...oined Mirus in 2005. Before that, he was director ...
...cline in research revenue led Third Wave Technolo...nts a share, but because the loss was expected sha...ompany in transition, Third Wave expected somethin...nical market, rather than research and a new CEO....ompared to 2004 revenue of $46.5 million. Its net ...
Other Biology Technology:Oracle out, Microsoft in for state e-mail project 2
(Date:12/4/2008)...inia Tech Wake Forest University,s School of Biom... Biomechanics has received the Army Modeling and S...eputy Chief of Staff of the Army and Director of t...d ultimately help save eyesight and reduce morbidi..., The center was selected from 57 applicants from...
(Date:12/4/2008)...le who carry weight in the thighs and backside hav...pressure and heart disease than apple-shaped peopl...rom nutrition researchers at Washington University...e comparisons don,t completely explain risk. , I...s to be the real key to insulin resistance, choles...
(Date:12/4/2008)...r women, often touting their intelligence and thei...nburg University and Oxford University that studie...hoose partners. , Research in the theory of evol... how men and women choose their partners. Among t...phasis on attractive appearance, whereas resources...
(Date:12/3/2008)...ecutive director of the International Energy Agenc...c. 9 at Rice University,s Baker Institute for Publ...s: Is the world facing a supply crunch because of ...t-Kyoto policy framework might stabilize greenhous...ct might such a policy framework have on future en...
Breaking Biology News(10 mins):New dummy design and development wins US Department of Defense award 2Apple or pear shape is not main culprit to heart woes -- it's liver fat 2Myth about 'dirty old men' supported by science 2'World Energy Outlook' to be presented at Rice University Dec. 9 2SEIU Launches Multi State Grassroots Campaign Calling on the Carlyle Group to Put Care Above Profits in Buyout of Nations Largest Nursing Home Chain 2784 1SEIU Launches Multi State Grassroots Campaign Calling on the Carlyle Group to Put Care Above Profits in Buyout of Nations Largest Nursing Home Chain 2784 2Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services 1026 1Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services 1026 2Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services 1026 3Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services 1026 4Assisted Suicide Wont Up Deaths for Vulnerable Groups 3A Study 2779 1Assisted Suicide Wont Up Deaths for Vulnerable Groups 3A Study 2779 2The American Red Cross Releases Book Devoted to Your Dogs Health Because Your Dog is Counting on You 2775 1The American Red Cross Releases Book Devoted to Your Dogs Health Because Your Dog is Counting on You 2775 2
...y focuses on how individuals use signals to influe...sing on pairs of individuals. However, the role co...tures is rarely studied. In a new paper from The A... Jessica Flack and David Krakauer study how power ...rk in a monkey society. Power structure is importa...
...ack dot on his computer screen. The dot ?which rep...grow," morphing into a mass with finger-like proje...nderbilt professor of cancer biology envisions a f...used to predict a tumor,s clinical progression and... last two years, he has headed a major effort to d...
...cient and sensitive "handles" for biological molec...they also can heat up fast--by tens of degrees in ...the molecules or help study them, according to sci... Institute of Standards and Technology (NIST) and ... often study nanoscale and even picoscale mechanic...
...eciably slow down the progress of the fatal brain ... by researchers from the Universities of Munich an...lanck Institute in Martinsried. To do this they us...g Mello and Andrew Fire, for which they were award...s a variant of the cattle disease BSE and the huma...
Other Biology News:Math model predicts cancer behavior 2Math model predicts cancer behavior 3Math model predicts cancer behavior 4New approach to BSE successful in lab 2New approach to BSE successful in lab 3
DAP12 Market Segment: Protein Kinases
Rabbit polyclonal to Flagellin ( Abpromise for all tested applications). Antigen: Synthetic peptide from the flagellin C terminal domain of Burkholderia pseudomallei.
Naphthol Blue Black, CI 20470
Novagen's Calf Liver tRNA is qualified for use in reticulocyte lysates for in vitro translation, and is the same supplement used in the Red Nova Lysate .
Biology Products: